Skip to content Skip to footer

Business of Cannabis: New York – State of Play Roundup

Business of Cannabis: New York - State of Play Roundup
Share this story
Share on twitter
Share on linkedin
Share on email

Business of Cannabis: New York brought some of the industry’s leading companies to the stage to share their insights and their knowledge. From growers, to consultants, the state of play sessions gave real insight straight from the source.

Mitch Baruchowitz, Managing Partner of Merida Capital

Mitch Baruchowitz, CEO of Merida Capital, talked about the state of play for Merida. Mitch continued the conversation about an equitable industry, changing perceptions and touched on some of the difficulties from moving from an illegal to a legal market. As for Merida’s prediction for the legal market in New York, Baruchowitz thinks that all predictions right now are too conservative: “Rational analysis is going to underestimate the New York market.”

Allan Gandleman, Head of NYCGPA with David O’Brien, President and Chief Executive Officer at Massachusetts Cannabis Business Association.

Allan Gandleman, Head of New York Growers and Processors Association sat down with Jonathan Rubin, CEO of New Leaf Data Services to discuss how small and mid-level growers remain relevant among the major players and how to build a vibrant and inclusive ecosystem. Gandleman laid out some of the legislative timeline and said “hopefully we’re looking at kind of an early 2022 timeline”.

Speaking on the progressive nature of the MRTA, Gandleman highlighted not only the social equity but the environmental elements of the act: “Part of the MRTA which is really notable is it’s kind of commitment to environmental sustainability, we all know the energy use of cannabis in Colorado et cetera, and you know here in New York we are favouring outdoor”.

Gary Santo, CEO of Tilt Holdings and Andrew Udell, Managing Editor of TheCannalysts.

Gary Santo, CEO of Tilt Holdings joined Andrew Udell, Managing Editor of TheCannalysts, for a state of play session. Santo further expanded on the Shinnecock Indian Nation partnership that Barre Hamp discussed earlier in the day. Santo stressed the importance of working to help provide Tribal Nations the assistance to create enterprises that they will continue to own and run: “It’s about building a true economic ecosystem that’s going to give back to the reservation and to the nation itself,” he said.

Santo discussed regulations, access to capital and brand structuring, but social equity was very much the core of his talk. “Social equity it’s not just about writing a cheque, or diversity in the people we hire, it’s really about digging into the community and trying to create that next wave of cannabis entrepreneurs and operators.”

Jennifer Drake, COO of Ayr Wellness

Jennifer Drake, Co-Chief Operating Officer of Ayr Wellness took the last state of play session with Andrew Udell.

Drake shared Ayr’s ambitions to “really to be the largest producer of high-quality flower in the country” and shared her excitement for new products such as Levia (a THC-infused seltzer) to come to the market.

She explored some of the difficulties of vertical integration, cultivation and providing quality products consistently saying: “Running a cannabis company is hard, so you’ve got to be really passionate about it.” She also stressed the importance of a good company culture, “because attracting and retaining that great talent is the only way you can do all of these hard things consistently well.”

Recent posts
May 19, 2022
Who Are Europe’s Medical Cannabis Patients?
May 5, 2022
Europe’s Pilot Trials Are a Tentative Step Towards Legal Medical Cannabis
April 28, 2022
The First Sales of Legal Adult-Use Cannabis in Europe Are Due in 2022
April 14, 2022
One Step Forward for CBD in the UK, but Questions Remain at Home and Abroad

Catch up on our newest articles that you might have missed

Untitled design (11)
May 19, 2022
Who Are Europe’s Medical Cannabis Patients?
The relatively close integration of medical cannabis into the European healthcare systems has contributed to a patient population and purchasing...
il-vagabiondo-Q7QCj-9-q3I-unsplash
May 5, 2022
Europe’s Pilot Trials Are a Tentative Step Towards Legal Medical Cannabis
Underlining the cautious approach Europe is taking to the liberalisation of medical cannabis are the pilot trial access schemes for...
vincent-ghilione-z54zUmYA9f8-unsplash
April 28, 2022
The First Sales of Legal Adult-Use Cannabis in Europe Are Due in 2022
Last week the first pilot project trial for the legalised sales of adult-use cannabis in Basel, Switzerland was approved by...
thomas-kelley--8iE9ykf3Us-unsplash
April 14, 2022
One Step Forward for CBD in the UK, but Questions Remain at Home and Abroad
The recent publishing of the list of CBD products with a valid Novel Foods application by the UK’s Food Safety...